Antimicrobial Innovation: How Zonova is Changing Healthcare from the Inside Out

In this episode of the Innovation Conversation, Dr. Georgia Fleet and Carla Southworth, co-founders of Zonova, discuss their journey in developing a novel antimicrobial technology aimed at reducing hospital-acquired infections.

They share insights into the importance of addressing antimicrobial resistance, and the feedback they have received from the healthcare market. The conversation also touches on regulatory hurdles, investor relations, and the broader applications of their technology beyond medical devices. Finally, they offer advice for aspiring entrepreneurs based on their experiences.

Chapters

00:00Introduction to Zonova and Its Founders

03:02The Problem of Hospital-Acquired Infections

05:52Founding Journey

09:01Market Feedback and Antimicrobial Resistance

12:14Regulatory Challenges and Manufacturing Plans

15:00Investor Relations and Startup Challenges

18:03Broader Applications of Antimicrobial Technology

21:02Personal Experiences and Advice for Entrepreneurs

Takeaways

• Zonova aims to reduce hospital-acquired infections with antimicrobial technology.
• 75% of catheterized patients experience urinary tract infections.
• The Founding journey is challenging but rewarding.
• Market feedback indicates a strong need for effective infection control solutions.
• Antimicrobial resistance is a growing global health crisis.
• Regulatory pathways vary by region and sector, complicating market entry.
• Investor relations require resilience and adaptability to rejection.
• Surrounding oneself with experienced advisors is crucial for success.
• The potential applications of antimicrobial technology extend beyond medical devices.
• Entrepreneurship requires patience and a long-term vision.